Precigen (PGEN) Profit After Tax (2012 - 2026)
Precigen (PGEN) posted quarterly Profit After Tax of -$7.9 million for Q1 2026, up 85.36% year-over-year from -$4.3 million in Q1 2025, and up 66.26% quarter-over-quarter from -$23.5 million in Q4 2025.
Analysis
Precigen (PGEN) Profit After Tax (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Profit After Tax for 15 consecutive years, with -$7.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax rose 85.36% year-over-year to -$7.9 million; the TTM figure through Mar 2026 stood at -$204.4 million (down 30.49% YoY), while the FY2025 annual figure was -$250.6 million, down 98.55% from the prior year.
- Profit After Tax rose to -$7.9 million in Q1 2026 per PGEN's latest filing, from -$23.5 million in the prior quarter.
- Across five years, Profit After Tax topped out at $87.4 million in Q3 2022 and bottomed at -$146.3 million in Q3 2025.
- Historically, Profit After Tax has averaged -$26.6 million across 5 years, with a median of -$22.7 million in 2023.
- Annual changes were most pronounced in 2022 — Profit After Tax surged 393.57% — and 2025, when it plunged 510.33%.
- Precigen's Profit After Tax stood at -$22.2 million in 2022, then sank by 49.06% to -$33.1 million in 2023, then soared by 40.32% to -$19.7 million in 2024, then dropped by 19.14% to -$23.5 million in 2025, then jumped by 66.26% to -$7.9 million in 2026.
- Business Quant data shows PGEN's Profit After Tax at -$7.9 million in Q1 2026, -$23.5 million in Q4 2025, and -$146.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Precigen | 2.56 Bn | 2.56 Bn | 52.17 Mn | 20.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.07 Mn |
| Mar 31, 2026 | -7.93 Mn |
| Dec 31, 2025 | -23.50 Mn |
| Sep 30, 2025 | -146.34 Mn |
| Jun 30, 2025 | -26.64 Mn |
| Mar 31, 2025 | -54.15 Mn |
| Dec 31, 2024 | -19.73 Mn |
| Sep 30, 2024 | -23.98 Mn |
| Jun 30, 2024 | -58.79 Mn |
| Mar 31, 2024 | -23.74 Mn |
| Dec 31, 2023 | -33.06 Mn |
| Sep 30, 2023 | -19.80 Mn |
| Jun 30, 2023 | -20.32 Mn |
| Mar 31, 2023 | -22.73 Mn |
| Dec 31, 2022 | -22.18 Mn |
| Sep 30, 2022 | 87.38 Mn |
| Jun 30, 2022 | -17.64 Mn |
| Mar 31, 2022 | -19.25 Mn |
| Dec 31, 2021 | -25.03 Mn |
| Sep 30, 2021 | -29.76 Mn |